- Synonyms(4R,5S,6S,7S,9R,10R,11E,13E,16R)-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-l-ribo-hexopyranosyl)-3-(dimethylamino)-β-d-glucopyranosyl]oxy]-7-(1-formylethenyl)-4-hydroxy-5-methoxy-9,16-dimethyl-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-β-d-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-di...
- Description
(4R,5S,6S,7S,9R,10R,11E,13E,16R)-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-l-ribo-hexopyranosyl)-3-(dimethylamino)-β-d-glucopyranosyl]oxy]-7-(1-formylethenyl)-4-hydroxy-5-methoxy-9,16-dimethyl-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-β-d-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-dien-2-one (17-methylenespiramycin I)
Spiramycin EP Impurity C is a fully characterized chemical compound used as a reference standard of API Spiramycin. The standard offered is compliant with regulatory guidelines. Spiramycin EP Impurity C is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 177584-13-3